Delivery Order SPE2DB20D3101-SPE2DB21FK5F5
- Not listed
- This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,839.24 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 8, 2021. The contract has a completion date of September 9, 2021 and was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is for the delivery of Veltassa 8.4 GM Powder Packets in quantities of 30 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $2,648.31 and an ultimate completion date of May 16, 2024. It is a firm fixed-price delivery order contract with no set-aside designation....
- This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,840.04 firm fixed-price delivery order contract is for the supply of 4,565,283,546 packets of the medication Veltassa 8.4 GM Powder. The contract has a completion date of July 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
- This federal contract award, valued at $2,485.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veltassa 8.4 GM powder packets, a medication used to treat hyperkalemia. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,082.82 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM Powder Packets, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2022 and was awarded on May 26, 2022. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.32, is a delivery order for the medication Veltassa 8.4 GM Powder Packet 30S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with a ceiling value of $18,009.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999 and running through November 2026. The contract provides for the delivery of Veltassa 8.4 GM Powder Packet 30S, a pharmaceutical product, to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Veltassa 8.4 GM powder packets. The award has a ceiling value of $4,899.12 and a period of performance through May 9, 2025. The contract is a firm fixed price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,155.47 firm fixed-price delivery order covers the supply of Veltassa 8.4 GM Powder Packets, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FK5F5Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veltassa 8.4 GM powder packets. The contract, valued at $6,103.92, was awarded on September 14, 2021 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This contract is a delivery order, with a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/14/21 |